General Information
Cidara Influenza CD388.SQ.2.05Lonestar
A Phase 2b Randomized, Double-blind, Placebo-controlled, Multicenter Dose Ranging Study to Evaluate Efficacy and Safety of CD388, a Novel Long-acting Antiviral Conjugate, for the Prevention of Influenza in Subjects not at Risk for Influenza Complications
| Protocol | CD388.SQ.2.05 |
|---|---|
| Identifier | |
| UID | 98c45049-0b04-4b34-97ba-1c09c4cc9d9e |
| Status | Cancelled |
| Phase | 2b |
| Category | Influenza / Adult |
| Launch Year | 2024 |
| NCT Number | - |
| Created | 2024-08-15 16:04 |
| Last Updated | 2025-02-04 21:21 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2024-09-13 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | No | |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Ebuh, MD, Valentine | VEbuh | No |
| Recruiter | - | No | |
| Coordinator | Hernandez, Leslie | LHernandez | No |
| Regulatory | Romero, Araselly | ARomero | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Cidara Therapeutics |
|---|---|
| Division | Cidara Therapeutics |
| Team | Cidara Therapeutics |
| Managing Site | Lonestar Clinical Research, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Parexel International |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Yellow |
| Currency | - |
